Treatment of major depressive disorder in the finnish general population

Depression and Anxiety

Volumn 26, Issue 11, 2009, Pages 1049-1059

  Hämäläinen, Juha ^a,b   Isometsä, Erkki ^a,c   Sihvo, Sinikka ^a   Kiviruusu, Olli ^a   Pirkola, Sami ^c   Lönnqvist, Jouko ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Eastern Health Centre   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

General population; Major depressive disorder; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT;

ADULT; ANXIETY DISORDER; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISABILITY; DISEASE SEVERITY; DIVORCE; DRUG USE; DYSTHYMIA; FEMALE; FINLAND; HEALTH CARE UTILIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; SEX DIFFERENCE;

ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; FEMALE; FINLAND; GUIDELINE ADHERENCE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PATIENT SATISFACTION; PRIMARY HEALTH CARE; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; RECURRENCE; SOCIOECONOMIC FACTORS;

EID: 70350741352     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20524     Document Type: Conference Paper

References (59)

1. Judd LL. A decade of antidepressant development: the SSRIs and beyond. J Affect Disord 1998;51:211-213.
2. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Int Med 1999;14: 569-580.
3. American Psychiatric Association. Practice Guideline for Treatment of Patients With Major Depressive Disorder. 2nd ed. Washington, DC: American Psychiatric Association Press; 2000.
4. National Institute for Clinical Excellence (NICE). Depression. Management of depression in primary and secondary care. Clinical guideline 23. Available at www.nice.org.uk/CG022NICEguideline. December 2004.
5. Isometsä E, Lindfors O, Pirkola S, et al. The national Finnish current care guidelines for the treatment of depression - an overview. Psychiatria Fennica 2003;34:181-196. (Pubitemid 39168681)
6. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders 1990 to 2003. N Engl J Med 2005;352:2515-2523.
7. Goldberg D, Privett M, Ustun B, Simon G, Linden M. The effects of detection and treatment on the outcome of major depression in primary care: a naturalistic study in 15 cities. Br J Gen Pract 1998; 48:1840-1844. (Pubitemid 28552140)
8. Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001;58:55-61. (Pubitemid 32057765)
9. Simon GE, Fleck M, Lucas R, Bushnell DM. Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry 2004;161:1626-1634. (Pubitemid 39201460)
10. Reseland S, Bray I, Gunnell D. Relationship between antidepressant sales and secular trends in suicides in the Nordic countries. Br J Psychiatry 2006;188:354-358.
11. Katz SJ, Kessler RC, Lin E, Wells KB. Medication management of depression in the United States and Ontario. J Gen Int Med 1998;13:77-85. (Pubitemid 28092938)
12. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder. JAMA 2003;289:3095-3105.
13. Hämäläinen J, Isometsä E, Sihvo S, Pirkola S, Kiviruusu O. Use of health services for major depressive and anxiety disorders in Finland. Depress Anxiety 2008;25:27-37. (Pubitemid 351213922)
14. Wittchen HU, Lieb R, Wunderlich U, Schuster P. Comorbidity in primary care: presentation and consequences. J Clin Psychiatry 1999;60:29-36. (Pubitemid 29227664)
15. Aromaa A, Koskinen S., eds. Health and functional capacity in Finland. Baseline results of the Health 2000. Health Examination Survey. Helsinki: Publications of the National Public Health Institute;2003.
16. Pirkola SP, Isometsä E, Suvisaari J, et al. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population. Soc Psychiatry Psychiatr Epidemiol 2005;40:1-10.
17. Perälä J, Suvisaari J, Saarni S, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007;64:19-28. (Pubitemid 46041735)
18. Laukkala T, Isometsä E, Hämäläinen J, Heikkinen M, Lindeman S, Aro H. Antidepressant treatment of depression in the Finnish general population. Am J Psychiatry 2001;158: 2077-2079. (Pubitemid 33104121)
19. Alonso J, Angermeyer MC, Bernert S, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders. Acta Psychiatr Scand 2004; 109:55-64. (Pubitemid 38686197)
20. Bebbington PE, Brugha TS, Meltzer H, Jenkins R, Ceresa C, Farrell M, Lewis G. Neurotic disorders and the receipt of psychiatric treatment. Psychol Med 2000;30:1369-1376. (Pubitemid 30831019)
21. Mechanic D. Barriers to help-seeking, detection, and adequate treatment for anxiety and mood disorders: implications for health care policy. J Clin Psychiatry 2007;68:20-26. (Pubitemid 46333562)
22. Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Engl J Med 1999;341:1329-1335. (Pubitemid 29503571)
23. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States. Arch Gen Psychiatry 2005;62:629-640.
24. Fernández A, Haro JM, Martinez-Alonso M, et al. Treatment adequacy for anxiety and depressive disorders in six European countries. Br J Psychiatry 2007;190:172-173. (Pubitemid 46256195)
25. Sclar DA, Robinson LM, Skaer TL, Galin RS. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters. Int J Psychiatry Med 1998;28:407-419.
26. Kisely S, Linden M, Bellantuono C, Simon G, Jones J. Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study. Psychol Med 2000;30: 1217-1225.
27. Alegria M, Bijl RV, Lin E, Walters EE, Kessler RC. Income differences in persons seeking outpatient treatment for mental disorders: a comparison of the United States with Ontario and the Netherlands. Arch Gen Psychiatry 2000;57:383-391. (Pubitemid 30202330)
28. Kivimäki M, Gunnell D, Lawlor DA, et al. Social inequalities in antidepressant treatment and mortality: a longitudinal register study. Psychol Med 2006;37:373-382.
29. Wells KB. Depression in general medical settings, implications of three health policy studies for consultation-liasion psychiatry. Psychosomatics 1994;35:279-296.
30. Callahan EJ, Bertakis KD, Azari R, Helms LJ, Robbins J, Miller J. Depression in primary care: patient factors that influence recognition. Fam Med 1997;29:172-176. (Pubitemid 27132148)
31. Druss BG, Hoff RA, Rosenheck RA. Underuse of antidepressants in major depression: prevalence and correlates in a national sample of young adults. J Clin Psychiatry 2000;61:234-237.
32. Tylee A., Gastpar M., Lépine JP, Mendlewicz J. Identification of depressed patient types in the community and their treatment needs: findings from the DEPRES II (Depression Research in European Society II) Survey. Int Clin Psychopharmacol 1999; 14:153-165. (Pubitemid 29348768)
33. Spijker J, Bijl RV, de Graaf R, Nolen WA. Care utilization and outcome of DSM-III-R major depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand 2001; 104:19-24.
34. Olfson M, Marcus SC, Druss B, Pincus HA. National trends in the use of outpatient psychotherapy. Am J Psychiatry 2002; 159:1914-1920. (Pubitemid 35283259)
35. Weissman MM, Bland RG, Canino GJ, et al. Use of minor tranquilizers and antidepressant medications by depressed out-patients: results from the medical outcome study. Am J Psychiatry 1994;151:694-700.
36. Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption in the UK general population. J Clin Epidemiol 1998;51:273-283. (Pubitemid 28122077)
37. Valenstein M, Taylor KK, Austin K, Kales HC, McCarthy JF, Blow FC. Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry 2004;161: 654-661. (Pubitemid 38445509)
38. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002;63:817-825.
39. Simon GE, VonKorff M, Barlow W, Pabiniak C, Wagner E. Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol 1996;49:1067-1073. (Pubitemid 26319043)
40. Kirby M, Denihan A, Bruce I, Radic A, Coakley D, Lawlor BA. Benzodiazepine use among the elderly in the community. Int J Geriatr Psychiatry 1999;14:280-284.
41. Carney CE, Segal ZV, Edinger JD, Krystal AD. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. J Clin Psychiatry 2007;68:254-260.
42. Alonso J, Ferrer M, Romera B, Vilagut G, Angermeyer M, Bernert S, Brugha TS, Taub N, McColgen Z, de Girolamo G, Polidori G, Mazzi F, De Graaf R, Vollebergh WA, Buist- Bowman MA, Demyttenaere K, Gascuet I, Haro JM, Palacin C, Autonell J, Katz SJ, Kessler RC, Kovess V, Lépine JP, Abrabzadeh-Bouchez S, Ormel J, Bruffaerts R. The European Study of the Epidemiology of Mental Disorders (ESEMeD/ MHEDEA 2000) project: rationale and methods. Int J Methods Psychiatr Res 2002;11:55-67.
43. Kaye JA, Bradbury BD, Jick H. Changes in antipsychotic drug prescribing by general practioners in the United Kingdom from 1991 to 2000: a population-based observational study. Br J Clin Pharmacol 2003;56:569-575.
44. Barbee JG, Conrad EJ, Jamhour NJ. The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder. J Clin Psychiatry 2004;65:975-981.
45. Tiemeier H, de Vries WJ, van het Loo M, et al. Guideline adherence rates and interprofessional variation in a vignette study of depression. Qual Saf Health Care 2002;11:214-218.
46. Kniesner TJ, Powers RH, Croghan TW. Provider type and depression treatment adequacy. Health Policy 2005;72: 321-332.
47. Fernández A, Haro JM, Codony M, et al. Treatment adequacy of anxiety and depressive disorders: primary versus specialised care in Spain. J Affect Disord 2006;96:9-20. (Pubitemid 44566405)
48. Vuorilehto MS, Melartin TK, Rytsälä HJ, Isometsä ET. Do characteristics of patients with major depressive disorder differ between primary and psychiatric care? Psychol Med 2007;5:1-12.
49. Hall D, Wiles DH, Mc Creadie RG. Compliance with antidepressant medication. Br J Psychiatry 1990;157:453-454.
50. Wyshak G, Barsky A. Satisfaction with and effectiveness of medication care in relation to anxiety and depression. Patient and physician ratings compared. Gen Hosp Psychiatry 1995;17: 108-114.
51. Meredith LS, Orlando M, Humphrey N, Camp P, Sherbourne CD. Are better ratings of the patient-provider relationship associated with higher quality care for depression? Med Care 2001;39:349-360.
52. Van Voorhees BW, Cooper LA, Rost KM, et al. Primary care patients with depression are less accepting of treatment than those seen by mental health specialists. J Int Med 2003; 18:991-1000.
53. Kessing LV, Hansen HV, Ruggeri M, Bech P. Satisfaction with treatment among patients with depressive and bipolar disorders. Soc Psychiatry Psychiatr Epidemiol 2006;41:148-155. (Pubitemid 43309074)
54. Sturm R, Jackson CA, Meredith LS, et al. Mental health care utilization in prepaid and fee-for-service plans among depressed patients in the Medical Outcome Study. Health Serv Res 1995; 30:319-340.
55. Malt UF, Robak OH, Madsbu HP, Bakke O, Loeb M. The Norwegian naturalistic treatment study of depression in general practice (NORDEP): randomized double blind study. BMJ 1999;318:1180-1184. (Pubitemid 29201575)
56. Chilvers C, Dewey M, Fielding K, et al. Antidepressant drugs and general counselling for treatment of major depression in primary care: randomized trial with patient preference arms. BMJ 2001;322:1-5.
57. Howard KI, Kopta SM, Krause MS, Orlinsky DE. The dose-effect relationship in psychotherapy. Am Psychol 1986; 41:159-164.
58. Lutz W, Lowry J, Kopta SM, Einstein DA, Howard KI. Prediction of dose-response relations based on patient characteristics. J Clin Psychol 2001;57:889-900. (Pubitemid 32566005)
59. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. JAMA 2002;287:203-209. (Pubitemid 34251945)